News

John Dolan independent vocational candidate

A new initiative taking the fight to MS

This week Niamh looks at the adjustments she has made to improve her general well-being.

Memory, attention and concentration

Get Active for MS and sign-up for VHI Women’s Mini Marathon taking place on 6th June 2016

This week Emma Rogan takes a look at research, how things have changed in the Multiple Sclerosis Community, what the successes have been and what areas remain relatively unexamined.   

Strategic plan for the National Medical Card Unit.

March' s self-management series 

We have been notified by Biogen that the production of the lyophilised form of Avonex (interferon beta-1a) BIO-SET which is used in the treatment of relapsing-remitting MS or clinically isolated syndrome, is being discontinued. This decision has been taken in view of the availability of alternative treatments and the diminishing market demand for the lyophilised form and is not due to any safety issues. This is the only presentation of Avonex that is being discontinued.

Save the date